1645.HK $0.90 -3.2258%
ASGI $17.73 0.4134%
GLBE $29.90 -2.8437%
TJX $78.22 0.205%
JAR.L $47.68 -23.712%
0312.HK $0.10 4.2105%
AVNT $38.26 -0.9707%
2125.HK $0.97 0%
CWBC $11.19 5.4665%
2MX.PA $7.46 0%
ETG $15.85 -0.9994%
RBAC-UN $10.01 0%
NK.PA $36.26 1.0591%
CCRO3.SA $13.57 -0.5861%
PEGRW $0.07 18.9744%
0VGI.L $31.29 -6.4115%
RVNC $34.47 -3.4994%
0JD3.L $10.65 -0.0563%
0883.HK $12.62 -1.5601%
0K9O.L $25.09 4.0871%
AGBAR $0.55 0%
BKR $27.64 1.0234%
KRNT $22.05 1.4726%
0P0001C5T8.L $10 219.20 0.2551%
BURY.CN $0.22 0%
MRAI $0.68 3.0046%
LQDH.L $96.22 0.0936%
FLXS $17.00 1.3715%
IRIX $2.24 -0.4444%
0LO3.L $172.30 0.1715%
ARAY $3.55 -2.6099%
ROCK $53.70 -1.7115%
WFG $73.86 -0.4985%
0HST.L $54.46 0.1648%
DYAI $1.95 2.6316%
WMS $85.09 -1.5162%
FLMX $30.62 -0.3041%
TAIT $3.61 0.5014%
CLIM-UN $10.03 0%
1901.HK $0.86 1.1765%
CMIIW $2.68 0%
LI.PA $21.09 -1.3103%
1686.HK $4.30 -0.463%
ENIC $3.05 0.3289%
DAC $56.37 -0.5118%
2292.HK $0.91 2.24719%
ALTU $10.10 0%
DC.L $137.80 0%
GPRO $3.87 1.0458%
0HRJ.L $31.81 0.6288%
LINX $7.50 0%
FITBI $24.14 0.3742%
MLABO.PA $0.96 0%
HEP $16.40 -0.6061%
SRT $3.19 4.482%
IO $0.35 0%
2278.HK $3.19 0%
ALLHB.PA $57.50 0%
NETI $8.18 -0.2439%
EUCA4.SA $10.22 5.3608%
0HGM.L $35.72 -2.9612%
JZXN $0.19 1.3122%
SCIN.L $895.00 0%
2824.HK $61.58 0%
PRTH $3.62 -1.0929%
INDF $32.68 0.755%
PIER.L $58.35 -1.1017%
LTI.L $1 050.00 1.2048%
ZGN $12.89 0.3972%
C09.SI $7.01 0.5739%
BBH.L $153.00 -0.3906%
ADVI.PA $20.20 0%
BIOC $0.25 1.1124%
PZT $22.82 -0.0088%
IOR $11.00 0%
1660.HK $0.36 2.8985%
KPLT $0.69 2.2534%
1498.HK $1.05 0%
0QZ5.L $61.65 -0.6639%
2230.HK $0.18 -0.5464%
0QSS.L $1.03 1.1152%
JOET $26.91 -0.2816%
NWN $45.59 -0.805%
KSU-P $37.42 0%
AMJ $22.02 0.4104%
0869.HK $0.75 4.1667%
FLWS $9.36 0.3755%
HON.L $159.07 0%
TAYN.PA $1.21 0%
3040.HK $26.88 0.4484%
0JZ2.L $172.76 0.9584%
EEH $32.45 0%
GAL.L $19.00 -0.5236%
PCOM.L $10.53 -0.3783%
ILCB $56.29 -0.6881%
TXN $160.53 -0.3971%
HACK $45.46 -0.9911%
8100.HK $0.22 0%
ING.L $110.30 -1.0762%
GOLF $45.74 -1.6767%
Eng
Логотип
Eng
Лого

MaaT Pharma SA MAAT.PA

$8.54

+$0.35 (4.15%)
На 18:05, 12 мая 2023

Ключевые показатели

  • Marketcap

    100224870.00000000

  • week52high

    12.90

  • week52low

    7.40

  • Revenue

    1430000

  • P/E TTM

    -6

  • Beta

    0.00000000

  • EPS

    -1.31000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    08 ноя 2022 г. в 18:00

Описание компании

MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек